APVO - Aptevo Therapeutics Inc.
0.39
-0.020 -5.128%
Share volume: 715,589
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.41
-0.02
-0.05%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-08-2024 | 08-10-2023 | 11-14-2023 | 02-14-2025 | 05-08-2024 | 08-08-2024 | 11-07-2024 | 02-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 7.756 M | 8.178 M | 6.561 M | 6.383 M | 6.983 M | 6.024 M | 5.213 M | 6.382 M | |
| Selling general and admin | 3.588 M | 2.716 M | 2.674 M | 2.793 M | 3.231 M | 2.381 M | 2.110 M | 2.502 M | |
| Research and development | 4.168 M | 5.462 M | 3.887 M | 3.590 M | 3.752 M | 3.643 M | 3.103 M | 3.880 M | |
| Total expenses | 7.756 M | 8.178 M | 6.561 M | 6.383 M | 6.983 M | 6.024 M | 5.213 M | 6.382 M | |
| 5.44% | -19.77% | -2.71% | 9.40% | -13.73% | -13.46% | 22.42% | |||
| Operating income | -7.756 M | -8.178 M | -6.561 M | -6.383 M | -6.983 M | -6.024 M | -5.213 M | -6.382 M | |
| Ebit | 1.894 M | -8.178 M | -6.561 M | -6.383 M | -6.983 M | -6.024 M | -5.213 M | -6.382 M | |
| Pretax income | 1.894 M | -8.178 M | -6.561 M | -6.383 M | -6.983 M | -6.024 M | -5.213 M | -6.382 M | |
| -531.78% | -19.77% | -2.71% | 9.40% | -13.73% | -13.46% | 22.42% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 2.773 M | -7.948 M | -6.334 M | -5.902 M | -6.834 M | -5.883 M | -5.101 M | -6.312 M | |
| -386.62% | 20.31% | 6.82% | -15.79% | 13.92% | 13.29% | -23.74% |
